Top Markets
Coin of the day
Lumos Diagnostics Holdings Limited Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited

LDX
株式のランク #23727
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes... Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
株価
$0.0740549
最終同期: 2026-08-21
時価総額
$69.97M
変化(1日)
0.00%
変化(1年)
21.33%
AU
取引 Lumos Diagnostics Holdings Limited (LDX)

カテゴリー

Lumos Diagnostics Holdings Limited(LDX)の配当利回りの履歴
Lumos Diagnostics Holdings Limited(銘柄コード: LDX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Lumos Diagnostics Holdings Limited(LDX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)